Amy Schumer Had ‘Chocolate Cysts,' ‘Choked' Appendix From Endometriosis: ‘Miracle That I Was Able to Carry a Child'
Amy Schumer said she was 'vomiting from the pain' before her 2021 endometriosis diagnosis
The comic gave a surprise speech at the 13th Annual Endometriosis Foundation of America's Blossom Ball in New York City, where she thanked Dr. Tamer Seckin for lifting "the pain" from her body
Schumer said her appendix was 'choked' by endometriosis, which gave her "chocolate cysts" in her ovaries. She said it was a 'miracle" she could carry her son GeneAmy Schumer said she was 'on the floor in pain" and "vomiting' because of endometriosis before her diagnosis, explaining that her body was essentially 'choked' by the effects of the disease.
The Kinda Pregnant actress, 43, had a hysterectomy and an appendectomy to help treat the disease in September 2021. Four years later, Schumer took the stage on Thursday, May 15, for a surprise speech at the 13th Annual Endometriosis Foundation of America's Blossom Ball at The Pierre in New York City.
In her speech at the event, Schumer told the crowd she was living in "pain that nobody can see" for "most days of the month" before receiving her official diagnosis of endometriosis.
The condition "is a disease in which tissue similar to the lining of the uterus grows outside the uterus," according to the World Health Organization, which estimates that approximately 190 million women worldwide have the disease.
It wasn't until the 2019 birth of her son, Gene David Fischer, whom she shares with husband Chris Fischer, that Schumer said her doctor diagnosed her with endometriosis and adenomyosis — when tissue grows into the uterine wall — and sent her to see Dr. Tamer Seckin, founder of the advocacy group EndoFound.
Schumer said it was 'a unique experience to have the proof for the first time. To sit down in his office, and have him go through and show me the 33 [attachments] that I had from endo. That my appendix was being choked by endometriosis.
"That I had chocolate cysts [which are full of old blood] in my ovaries," Schumer continued. "And that it was a miracle that I was able to carry a child.'
The conversation, she said, left her 'just weeping and weeping and weeping.'
'Sitting there, feeling seen, he lifted the pain out of my body. I am pain-free now for about five or six years,' Schumer said.
She then used her signature stand-up comedy to thank Dr. Seckin for deciding to 'not focus in the medical field on what so many do, which is d—k pills, right?"
She joked, "We'll get to the women next lifetime.'
Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories.
Schumer previously opened up about how her diagnosis for endometriosis changed her life. While appearing on the Paramount+ docuseries The Checkup with Dr. David Agus in 2022, Schumer said getting treatment for the disease even changed how she parented her young son.
"I felt like a new person. It was incredible," she said at the time. "I feel like someone lifted this veil that had been over me and I just felt like a different person and like a new mom."
Read the original article on People
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
Pennsylvania joins list of Age-Friendly States
(WHTM) — Governor Josh Shapiro announced Pennsylvania's designation as an Age-Friendly State on Thursday. The designation, awarded by AARP and the World Health Organization, recognizes the commonwealth's commitment to being a positive community for people to grow up and grow older, according to a press release from the Department of Aging. Close Thanks for signing up! Watch for us in your inbox. Subscribe Now One in three Pennsylvanians is older than 60, accounting for 3.8 million people, according to the department. Pennsylvania is just 1 of 13 states with the Age-Friendly designation. 'My Administration is fighting for Pennsylvanians every day, and that includes investing in and building a Commonwealth that cares for and supports older adults,' Shapiro said. Shapiro made the announcement alongside Secretary of Aging Jason Kavulich at the White Rose Senior Center in York. In 2020, York County became an Age-Friendly Community. Now, all of the state's 67 counties share the designation. 'There's no one-size-fits-all solution when it comes to projects or plans that concern where we live, work, and play,' said Cathy Bollinger, executive director of Embracing Aging with the York County Community Foundation. 'And that is especially true for our seniors as well. By asking ourselves 'does it work for people of all ages?' we ensure that creativity and flexibility guide every decision — especially those related to housing and transportation. When we collaborate and plan this way, we create the potential to transform the quality of life for all residents — no matter their age.' Maple Donuts in York County has been sold Shapiro has made supporting older Pennsylvanians a priority of his administration. A year ago, he launched the Aging Our Way, PA program — a 10-year strategic plan to support older adults with a focus on access to public transport, caregivers, housing and reduced prescriptions and insurance, according to the program's website. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
CBS News
6 hours ago
- CBS News
Removing fluoride from water could result in 25 million cavities and cost $9.8 billion, study estimates
New research suggests that removing fluoride from public water would increase dental care costs and tooth decay for children across the United States. The study, published Friday in the JAMA Health Forum, used a nationally representative sample of 8,484 children aged 0 to 19 from the U.S. National Health and Nutrition Examination Survey to estimate projected outcomes of stopping water fluoridation in the U.S. — something some states, including Utah and Florida, have already begun doing. Researchers found removing fluoride was associated with an increase in tooth decay of 7.5 percentage points, or 25.4 million cases, and cost approximately $9.8 billion over 5 years. These effects would disproportionately affect publicly insured and uninsured children, who are already at the highest risk of unmet dental needs, the authors added. Fluoride is a mineral that helps strengthen teeth and reduce cavities, according to the Centers for Disease Control and Prevention. It does this by repairing and preventing damage to teeth caused by bacteria in the mouth that produce acid, which in turn dissolves minerals in a tooth's surface and can even lead to tooth loss. Tooth decay by itself can be painful and costly to treat but left untreated can cause further problems, including infections and abscesses or even sepsis, according to the World Health Organization. Some research has also linked poor oral health to other complications, such as cardiovascular disease due to inflammation and infection. The addition of low levels of fluoride to drinking water was long considered one of the greatest public health achievements of the last century, but Health and Human Services Secretary Robert F. Kennedy Jr. has brought it into question, claiming fluoride is linked to a slew of health problems. Dental experts have told CBS News they largely disagree. "Seventy years of research, thousands of studies and the experience of more than 210 million Americans tell us that water fluoridation is effective in preventing cavities and is safe for children and adults," according to the American Dental Association. Fluoride can come from a number of sources, including most toothpaste brands, but researchers say drinking water is the main source for Americans. Plus, the U.S. Food and Drug Administration announced earlier this year that it is starting the process of removing ingestible fluoride prescription drug products for kids from the market.
Politico
8 hours ago
- Politico
Rare disease funding imperiled
WORLDVIEW The State Department wants to stop funding neglected tropical diseases because it doesn't make Americans safer, it said in its budget request for the 2026 fiscal year. The department has also ended most ongoing projects fighting these diseases as part of the Trump administration's foreign aid review, which aimed to bring it in line with the president's 'America First' policy. Why it matters: That's going to make it harder and take longer to eliminate these diseases, said Angela Weaver, the vice president for neglected tropical diseases at Helen Keller International, a U.S. nonprofit. Neglected tropical diseases are a group of diverse conditions caused by viruses, bacteria and other pathogens which can have devastating health, social and economic consequences among impoverished communities in tropical areas, according to the World Health Organization. The group includes lymphatic filariasis, also known as elephantiasis, a parasitic infection caused by worms that can lead to severe swelling; and trachoma, a bacterial eye infection that can leave people blind if untreated. 'We were on the brink of elimination for some of these diseases, especially in the countries that fall under my portfolio, because they happen to be countries where USAID started investing first: Mali, Burkina Faso,' Weaver said, referring to the U.S. Agency for International Development that the Trump administration has dismantled. How we got here: USAID funded the fight against five neglected tropical diseases starting in 2006, reaching a budget of up to $115 million in 2024, according to KFF, a nonpartisan health think tank. That investment delivered results, Weaver said. 'When the U.S. investment started, the entire country of Mali was at risk for blinding trachoma. And two years ago, it was declared by the World Health Organization that it's no longer a public health problem,' she said. 'And this is through successive coups, Covid, all kinds of political instability, insecurity,' Weaver said. Pharmaceutical companies like MSD and Pfizer have donated drugs to treat some of these diseases. 'It was truly a partnership. What the U.S. brought was just some really much needed implementation money to get drugs from point A to point B, into the mouths of people that need them, in an efficient and safe way,' Weaver said. The future of continuing to fight these diseases is uncertain, as pharmaceutical companies, philanthropies or other governments don't appear willing to help cover some of the gap the U.S. is leaving. 'We have an opportunity to eliminate some of these diseases that have been around for generations and generations,' Weaver said. 'Taxpayer dollars … have already been invested in this program, and we're kind of throwing that away if we just let these programs go completely,' she said. WELCOME TO FUTURE PULSE This is where we explore the ideas and innovators shaping health care. The FDA is rolling out an AI tool to assist with scientific reviews this week and a podcast to explain what it's up to. Share any thoughts, news, tips and feedback with Danny Nguyen at dnguyen@ Carmen Paun at cpaun@ Ruth Reader at rreader@ or Erin Schumaker at eschumaker@ Want to share a tip securely? Message us on Signal: Dannyn516.70, CarmenP.82, RuthReader.02 or ErinSchumaker.01. FOLLOW THE MONEY The prospect of pharmaceutical tariffs is front-of-mind in both Europe and Washington, according to POLITICO reports. On Capitol Hill, most Republicans on the tax-writing Ways and Means Committee recently warned Commerce Secretary Howard Lutnick to be careful with drug tariffs, our Ari Hawkins reported. The 20 lawmakers, led by Reps. Nicole Malliotakis (R-N.Y.) and Greg Murphy (R-N.C.), told Lutnick it's fine with them to target China but not U.S. allies. 'We urge you to consider whether tariffs on medicines sourced from allies such as Australia, Canada, the European Union, Japan, Switzerland, and the United Kingdom could have significant negative effects on American patients,' they wrote. Meanwhile, in Brussels, European Commission President Ursula von der Leyen has asked CEOs across the pond to provide details on their plans for investing in the U.S. in preparation for trade talks. Some of the biggest U.S. investment announcements from Europe so far have come from the pharmaceutical sector, with Swiss firms Roche and Novartis pledging $50 billion and $23 billion, respectively. France's Sanofi has committed at least $20 billion through 2030. The backstory: President Donald Trump announced in April he was considering using a national security law to impose pharmaceutical tariffs to encourage more domestic manufacturing. The United States imported roughly $210 billion worth of pharmaceutical products in 2024, according to data from the Commerce Department. A federal trade court last week blocked broader tariffs on consumer goods that the administration had used emergency powers to impose, but a federal appeals court stayed the decision while it considers arguments. What's next? The Trump administration hasn't formally released any details on the size or target of any pharmaceutical tariffs it's weighing, but Trump told reporters last month that the duties could be anywhere from 25 percent up to 200 percent.
